China biotech boom leaves U.S. scrambling
from AXIOS: China biotech boom leaves U.S. scrambling By Adriel Bettelheim and Maya Goldman Illustration: Sarah Grillo/Axios China is now setting the pace in life sciences R&D, conducting more clinical trials than the U.S. and licensing new discoveries to American companies. The big picture: Beijing has become a linchpin in global drug development, the result of a decade-long national strategy […]
China biotech boom leaves U.S. scrambling Read More »
